The earlier, the smaller, the better for natalizumab-associated PML: in MRI vigilance veritas?
MYelin Disorders REseArch teaM, Liège, France. remy.phanba@chu.ulg.ac.be
Rémy
R
Phan-Ba
Shibeshih
S
Belachew
Olivier
O
Outteryck
Gustave
G
Moonen
Christian
C
Sindic
Mathieu
M
Vokaer
Patrick
P
Vermersch
D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D001921:Brain / Q000473:pathology*; D005260:Female; D006801:Humans; D007968:Leukoencephalopathy, Progressive Multifocal / Q000139:chemically induced* / Q000175:diagnosis* / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D000069442:Natalizumab
D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab